Veterinary Medicines

Vanguard CPV solution for injection for dogs

Authorised
  • Canine parvovirus, strain NL-35-D, Live
Download as PDF

Product identification

Medicine name:
Vanguard CPV solution for injection for dogs
Active substance:
  • Canine parvovirus, strain NL-35-D, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain NL-35-D, Live
    316228000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 100vials of 1 ml liquid Vanguard CPV.
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 25vials of 1 ml liquid Vanguard CPV.
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 10vials of 1 ml liquid Vanguard CPV.
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 1vial of 1 ml liquid Vanguard CPV.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/083/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 9/03/2025
Download